This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lexicon Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Jun Yan: Pioneering AAK1 Inhibitors
Introduction: Jun Yan, an accomplished inventor based in Changzhou, China, has made significant contributions to the field of pharmaceutical chemistry. With a keen focus on innovative methods and compounds, he has developed a noteworthy patent that showcases his expertise and commitment to advancing medical science.
Latest Patents: Jun Yan holds a patent for "Methods and compounds useful in the synthesis of an AAK1 inhibitor." This innovative work details methods for synthesizing (S)-1-((2',6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine, along with its useful compounds and related salts. This patent represents a key step in developing new therapeutic options for treating various health conditions.
Career Highlights: Currently, Jun Yan is employed at Lexicon Pharmaceuticals, Inc., where he continues to push the boundaries of drug discovery and development. His work at Lexicon has not only contributed to his personal growth but has also added invaluable resources to the company’s innovative portfolio.
Collaborations: Jun Yan collaborates closely with fellow researchers, including Tao Chen and Wenxue Wu. Together, they contribute to a collaborative environment that fosters the exchange of ideas and promotes cutting-edge research in the pharmaceutical industry.
Conclusion: Through his innovative patent and collaborative efforts, Jun Yan exemplifies the spirit of invention that drives the pharmaceutical field forward. His contributions at Lexicon Pharmaceuticals, Inc. and partnerships with dedicated colleagues highlight his commitment to improving healthcare solutions through scientific innovation.